Report Detail
Global PET Radiopharmaceuticals Market Insights, Forecast to 2025
- RnM2883592 |
- 08 February, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
The global PET Radiopharmaceuticals market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the PET Radiopharmaceuticals market based on company, product type, end user and key regions.
This report studies the global market size of PET Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of PET Radiopharmaceuticals in these regions.
This research report categorizes the global PET Radiopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global PET Radiopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Market size by Product
F-18
Ru-82
Others
Market size by End User
Oncology
Cardiology
Neurology
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global PET Radiopharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of PET Radiopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global PET Radiopharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of PET Radiopharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of PET Radiopharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of PET Radiopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 PET Radiopharmaceuticals Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Product
- 1.4.2 F-18
- 1.4.3 Ru-82
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global PET Radiopharmaceuticals Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Cardiology
- 1.5.4 Neurology
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global PET Radiopharmaceuticals Market Size
- 2.1.1 Global PET Radiopharmaceuticals Revenue 2014-2025
- 2.1.2 Global PET Radiopharmaceuticals Sales 2014-2025
- 2.2 PET Radiopharmaceuticals Growth Rate by Regions
- 2.2.1 Global PET Radiopharmaceuticals Sales by Regions
- 2.2.2 Global PET Radiopharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 PET Radiopharmaceuticals Sales by Manufacturers
- 3.1.1 PET Radiopharmaceuticals Sales by Manufacturers
- 3.1.2 PET Radiopharmaceuticals Sales Market Share by Manufacturers
- 3.1.3 Global PET Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
- 3.2 PET Radiopharmaceuticals Revenue by Manufacturers
- 3.2.1 PET Radiopharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 PET Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
- 3.3 PET Radiopharmaceuticals Price by Manufacturers
- 3.4 PET Radiopharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 PET Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers PET Radiopharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into PET Radiopharmaceuticals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global PET Radiopharmaceuticals Sales by Product
- 4.2 Global PET Radiopharmaceuticals Revenue by Product
- 4.3 PET Radiopharmaceuticals Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global PET Radiopharmaceuticals Breakdown Data by End User
6 North America
- 6.1 North America PET Radiopharmaceuticals by Countries
- 6.1.1 North America PET Radiopharmaceuticals Sales by Countries
- 6.1.2 North America PET Radiopharmaceuticals Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America PET Radiopharmaceuticals by Product
- 6.3 North America PET Radiopharmaceuticals by End User
7 Europe
- 7.1 Europe PET Radiopharmaceuticals by Countries
- 7.1.1 Europe PET Radiopharmaceuticals Sales by Countries
- 7.1.2 Europe PET Radiopharmaceuticals Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe PET Radiopharmaceuticals by Product
- 7.3 Europe PET Radiopharmaceuticals by End User
8 Asia Pacific
- 8.1 Asia Pacific PET Radiopharmaceuticals by Countries
- 8.1.1 Asia Pacific PET Radiopharmaceuticals Sales by Countries
- 8.1.2 Asia Pacific PET Radiopharmaceuticals Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific PET Radiopharmaceuticals by Product
- 8.3 Asia Pacific PET Radiopharmaceuticals by End User
9 Central & South America
- 9.1 Central & South America PET Radiopharmaceuticals by Countries
- 9.1.1 Central & South America PET Radiopharmaceuticals Sales by Countries
- 9.1.2 Central & South America PET Radiopharmaceuticals Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America PET Radiopharmaceuticals by Product
- 9.3 Central & South America PET Radiopharmaceuticals by End User
10 Middle East and Africa
- 10.1 Middle East and Africa PET Radiopharmaceuticals by Countries
- 10.1.1 Middle East and Africa PET Radiopharmaceuticals Sales by Countries
- 10.1.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa PET Radiopharmaceuticals by Product
- 10.3 Middle East and Africa PET Radiopharmaceuticals by End User
11 Company Profiles
- 11.1 Cardinal Health Inc. (U.S.)
- 11.1.1 Cardinal Health Inc. (U.S.) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Products Offered
- 11.1.5 Cardinal Health Inc. (U.S.) Recent Development
- 11.2 Mallinckrodt plc (Ireland)
- 11.2.1 Mallinckrodt plc (Ireland) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Products Offered
- 11.2.5 Mallinckrodt plc (Ireland) Recent Development
- 11.3 GE Healthcare (U.K.)
- 11.3.1 GE Healthcare (U.K.) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Products Offered
- 11.3.5 GE Healthcare (U.K.) Recent Development
- 11.4 Lantheus Medical Imaging, Inc. (U.S.)
- 11.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Products Offered
- 11.4.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Development
- 11.5 Bayer AG (Germany)
- 11.5.1 Bayer AG (Germany) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Products Offered
- 11.5.5 Bayer AG (Germany) Recent Development
- 11.6 Bracco Imaging S.p.A (Italy)
- 11.6.1 Bracco Imaging S.p.A (Italy) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Products Offered
- 11.6.5 Bracco Imaging S.p.A (Italy) Recent Development
- 11.7 Eczacibasi-Monrol Nuclear Products (Turkey)
- 11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Products Offered
- 11.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Development
- 11.8 Nordion, Inc. (Canada)
- 11.8.1 Nordion, Inc. (Canada) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Products Offered
- 11.8.5 Nordion, Inc. (Canada) Recent Development
- 11.9 Advanced Accelerator Applications S.A. (France)
- 11.9.1 Advanced Accelerator Applications S.A. (France) Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Products Offered
- 11.9.5 Advanced Accelerator Applications S.A. (France) Recent Development
- 11.10 IBA Molecular Imaging (Belgium)
- 11.10.1 IBA Molecular Imaging (Belgium) Company Details
- 11.10.2 Company Business Overview
- 11.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Products Offered
- 11.10.5 IBA Molecular Imaging (Belgium) Recent Development
12 Future Forecast
- 12.1 PET Radiopharmaceuticals Market Forecast by Regions
- 12.1.1 Global PET Radiopharmaceuticals Sales Forecast by Regions 2019-2025
- 12.1.2 Global PET Radiopharmaceuticals Revenue Forecast by Regions 2019-2025
- 12.2 PET Radiopharmaceuticals Market Forecast by Product
- 12.2.1 Global PET Radiopharmaceuticals Sales Forecast by Product 2019-2025
- 12.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Product 2019-2025
- 12.3 PET Radiopharmaceuticals Market Forecast by End User
- 12.4 North America PET Radiopharmaceuticals Forecast
- 12.5 Europe PET Radiopharmaceuticals Forecast
- 12.6 Asia Pacific PET Radiopharmaceuticals Forecast
- 12.7 Central & South America PET Radiopharmaceuticals Forecast
- 12.8 Middle East and Africa PET Radiopharmaceuticals Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 PET Radiopharmaceuticals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on PET Radiopharmaceuticals . Industry analysis & Market Report on PET Radiopharmaceuticals is a syndicated market report, published as Global PET Radiopharmaceuticals Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of PET Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
